Dr Ashish Khanna on the PRODIGY Trial and Risk Score
Dr Ashish Khanna, from Wake Forest School of Medicine, discusses his research on a novel opioid-induced respiratory depression risk score, its benefits for practice, and more.
Dr Ashish Khanna on the PRODIGY Trial and Risk Score
Dr Ashish Khanna, from Wake Forest School of Medicine, discusses his research on a novel opioid-induced respiratory depression risk score, its benefits for practice, and more.